Boothbay Fund Management, LLC Kodiak Sciences Inc. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 157,858 shares of KOD stock, worth $596,703. This represents 0.05% of its overall portfolio holdings.
Number of Shares
157,858
Previous 129,438
21.96%
Holding current value
$596,703
Previous $337,000
365.88%
% of portfolio
0.05%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding KOD
# of Institutions
109Shares Held
40.9MCall Options Held
28.4KPut Options Held
21.2K-
Baker Bros. Advisors LP New York, NY17.3MShares$65.4 Million1.91% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$14.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.68MShares$6.36 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.53MShares$5.79 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$4.79 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $197M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...